UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
06/11/2019 - 2 minutes
Melanoma
UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell…
03/09/2019 - 2 minutes
This Biotech Helps the Immune System to Infiltrate and Destroy Tumors
The Nice-based biotech company Yukin Therapeutics is developing drugs that can work together with checkpoint…
05/07/2019 - 3 minutes
Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”
Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer…
24/07/2018 - 6 minutes
British Cancer Vaccine Boosts 5-Year Survival in Late Stage Melanoma
Scancell has reported promising 5-year survival data for its cancer vaccine SCIB1, with a second trial expected…
13/02/2018 - 2 minutes
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100…
12/12/2017 - 2 minutes
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for…
13/11/2017 - 3 minutes
Swiss Researchers Unveil Cancer Immunotherapy Resistance Mechanism
Scientists from the University of Zurich have identified an epigenetic control switch responsible for turning…
27/07/2017 - 2 minutes
Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
30/06/2017 - 2 minutes
This French Biotech Wants to Reinvent DC-based Immunotherapies
This week we had the chance to visit both Grenoble and Liège, where the French-Belgian…
02/06/2017 - 2 minutes
Norwegian Biotech Goes for Combination Therapies in Melanoma
BerGenBio has started a new Phase I/II trial evaluating the addition of its Axl inhibitor…
22/05/2017 - 2 minutes
Cancer vaccines from the UK are entering the Fight against Lung Cancer
This week we made it all the way to Nottingham, UK, which is home to…
03/02/2017 - 2 minutes
